Health Policy & Advocacy
ASPHO is committed to advocating and achieving one voice for pediatric hematology/oncology. The Society works in partnership with appropriate organizations to advance its advocacy priorities such as:
- Ensure adequate federal funding for research, surveillance and other legislation
- Improve access to drugs, devices and biologics for children and adolescents
- Promote adequate payment for care of children by subspecialists in pediatric hematology/oncology to support needed access and workforce
The Advocacy Brief is a quarterly offering informing members about legislative and regulatory issues that have an impact on the pediatric hematology/oncology profession and the patients we serve. The digital publication is delivered directly to Society members' inboxes.
ASPHO participates in sign-on letters which are policy-oriented letters sent to members of Congress, congressional committees or federal agencies expressing the viewpoint of the signatories. By participating in sign-on letters, ASPHO represents the views of the organization and its members on policy-related issues.
Exciting new movement in legislation: Title VII and the Pediatric Specialty Loan Repayment Program were included in the CARES Act. Follow legislation that ASPHO is monitoring concerning pediatric hematology/oncology.
Many times, the best way to make an impact with a broad audience is to partner with a coalition that can help advance our priority issues. ASPHO belongs to the Alliance for Childhood Cancer and also the Sickle Cell Disease Coalition, the Emergency Department Sickle Cell Care Coalition, and the American Academy of Pediatrics.